Monitoring loss of striatal phosphodiesterase 10A (PDE10A) with [ 18 F]MNI-659 and PET: A biomarker of early Huntington disease (HD) progression. (I11-4A)
Russell D, Jennings D, Barret O, Tamagnan G, Carroll V, Alagille D, Morley T, Papin C, Seibyl J, Marek K. Monitoring loss of striatal phosphodiesterase 10A (PDE10A) with [ 18 F]MNI-659 and PET: A biomarker of early Huntington disease (HD) progression. (I11-4A). Neurology 2015, 84 DOI: 10.1212/wnl.84.14_supplement.i11-4a.Peer-Reviewed Original ResearchMonitoring loss of striatal phosphodiesterase 10A (PDE10A) with [ 18 F]MNI-659 and PET: A biomarker of early Huntington disease (HD) progression. (S15.004)
Russell D, Jennings D, Barret O, Tamagnan G, Carroll V, Alagille D, Morley T, Papin C, Seibyl J, Marek K. Monitoring loss of striatal phosphodiesterase 10A (PDE10A) with [ 18 F]MNI-659 and PET: A biomarker of early Huntington disease (HD) progression. (S15.004). Neurology 2015, 84 DOI: 10.1212/wnl.84.14_supplement.s15.004.Peer-Reviewed Original Research